Clinical Data S16 Ep52: Medical Crossfire: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application pharminent April 15, 2026
Clinical Data Spyre drug for inflammatory bowel disease shows promise in early study pharminent April 13, 2026
Clinical Data Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma pharminent April 13, 2026
Clinical Data Allogene stock sails after CAR T clears residual lymphoma in early data cut pharminent April 13, 2026
Clinical Data Revolution rises 40% as pancreatic cancer drug doubles survival pharminent April 13, 2026
Clinical Data Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease pharminent April 7, 2026
Clinical Data CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment pharminent April 7, 2026
Clinical Data Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off pharminent April 7, 2026
Clinical Data Sanofi immune drug hopeful posts mixed results in mid-stage tests pharminent April 7, 2026
Clinical Data Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3 pharminent April 7, 2026
Clinical Data ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH pharminent April 2, 2026
Clinical Data Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment pharminent April 2, 2026
Clinical Data ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity pharminent April 2, 2026
Clinical Data Viridian reports positive results from elegrobart phase 3 trial pharminent April 1, 2026
Clinical Data ACC 2026: dulaglutide promotes coronary plaque stabilisation in patients with T2D pharminent April 1, 2026
Clinical Data ACC 2026: Sotatercept shows signal in CpcPH-HFpEF at lower dose pharminent April 1, 2026
Clinical Data ACC 2026: Tonlamarsen lowers angiotensinogen without extra BP benefit pharminent April 1, 2026
Clinical Data PepGen Loses Half of Share Price on Mixed Data in Rare Muscle-Wasting Disease pharminent March 31, 2026
Clinical Data Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout pharminent March 30, 2026
Clinical Data Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline pharminent March 30, 2026
Clinical Data Wave crashes on obesity drug update; Kodiak’s reboot pays dividends pharminent March 26, 2026
Clinical Data Karyopharm myeloma drug yields mixed data in myelofibrosis trial pharminent March 24, 2026
